ConvaTec Group Plc

Equities

CTEC

GB00BD3VFW73

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:35:21 12/09/2024 BST 5-day change 1st Jan Change
230.00 GBX -0.09% Intraday chart for ConvaTec Group Plc -0.52% -5.81%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
FTSE 100 remains red ahead of US data AN
Jefferies likes Victrex; Barclays ups Elementis AN
Citi ups LondonMetric; UBS cuts Great Portland AN
FTSE 100 in the Red as Earnings Season Heats Up MT
Tech giants dish out the numbers amid Fed watch Our Logo
Investec Upgrades ConvaTec Group to Buy MT
Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla... Our Logo
ConvaTec seeks to allay US fears after first half progress AN
FTSE 100 underperforms after mixed earnings AN
ConvaTec Group PLC Provides Earnings Guidance for the Year 2024 CI
Transcript : ConvaTec Group PLC, H1 2024 Earnings Call, Jul 30, 2024
Convatec Group Posts Jump in H1 Attributable Profit, Revenue MT
Earnings Flash (CTEC.L) CONVATEC GROUP Posts H1 Revenue $1.11B MT
Earnings Flash (CTEC.L) CONVATEC GROUP Reports H1 EPS $0.04 MT
ConvaTec Group PLC Reports Earnings Results for the Half Year Ended June 30, 2024 CI
Quantum Corporation Appoints John R. Tracy as Director and as Member of the Audit Committee of the Board CI
Goldman Sachs Trims Convatec Group PT, Keeps Rating at Buy MT
Jefferies says buy Tritax Big Box post merger AN
ConvaTec Group PLC Provides Revenue Guidance for the Full Year 2024 CI
Transcript : ConvaTec Group PLC - Shareholder/Analyst Call
ConvaTec confident as company makes strong start in 2024 AN
Transcript : ConvaTec Group PLC, 4 Months Period Ending Apr 30, 2024 Sales/ Trading Statement Call, May 16, 2024
Convatec Group Posts Higher Four-month Revenue MT
Convatec Group plc Announces Trading Results for the Four Months Ended 30 April 2024 CI
Deutsche Bank Begins Convatec Group Coverage with Buy Rating MT
Chart ConvaTec Group Plc
More charts
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (32.5%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (28.4%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence and critical care (21.3%); - infusion (21.3%) ; - other (0.5%). At the end of 2023, the group operated 9 production sites worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (30.2%), Americas (55.4%) and Asia/Pacific (14.4%).
Employees
10,000
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.007USD
Average target price
3.790USD
Spread / Average Target
+26.05%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CTEC Stock
  4. News ConvaTec Group Plc
  5. FTSE 100 in the Red as Earnings Season Heats Up
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW